What is Acadia Pharmaceuticals's free cash flow yield?

Acadia Pharmaceuticals (ACAD) reported free cash flow yield of 5.5% in Q3 2025.

What is the long-term trend for Acadia Pharmaceuticals's free cash flow yield?

Over 2 years (2020 to 2022), Acadia Pharmaceuticals's free cash flow yield has grown at a 62.6% compound annual growth rate (CAGR), from -1.7% to -4.4%.

What does free cash flow yield mean?

Trailing-twelve-month free cash flow divided by market capitalization at the quarter end. The cash return the business generates relative to its market price.

Acadia Pharmaceuticals ACAD Free cash flow yield

Free cash flow yield at other companies

BiogenBIIB

9%-3.2pp

Neurocrine BiosciencesNBIX

6.3%+1.8pp

Catalyst PharmaceuticalCPRX

6.9%-2.2pp

PTC TherapeuticsPTCT

17.2%+14.6pp

BridgeBio PharmaBBIO

-3.1%—

Arrowhead ResearchARWR

0.5%+0.3pp

Other financials

Income statement

See full

Revenue$268.1M+9.7%

Gross profit$243.3M+8.6%

Operating income-$4.6M-124%

Net income$3.6M-80.8%

EPS (diluted)$0.02-81.8%

Balance sheet

See full

Cash & equivalents$282.2M+29.6%

Total debt$50.8M-9.3%

Total equity$1.2B+63.1%

Total assets$1.6B+41.8%

Cash flow

See full

Operating cash flow$34.0M+67.2%

CapEx$5.2M—

Free cash flow$28.8M+41.6%

Valuation

See full

Market cap$3.87B+37.0%

Profitability

See full

Gross margin91.5%-0.6pp

Operating margin7.4%-16.2pp

Net margin34.3%+11.3pp

FCF margin18.9%—

Returns & leverage

See full

Return on equity37.3%+0.1pp

Debt / equity0×0.0×

Current ratio3.6×+0.7×

Where this comes from

Calculated from Acadia Pharmaceuticals’s reported figures.

free cash flow/market cap=5.5%

Based on trailing twelve months.

The official record: Acadia Pharmaceuticals’s 10-Q, filed November 6, 2025, on SEC EDGAR. View the filing →

Ask your AI about Acadia Pharmaceuticals's free cash flow yield.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Acadia Pharmaceuticals's free cash flow yield?: Acadia Pharmaceuticals (ACAD) reported free cash flow yield of 5.5% in Q3 2025.
What is the long-term trend for Acadia Pharmaceuticals's free cash flow yield?: Over 2 years (2020 to 2022), Acadia Pharmaceuticals's free cash flow yield has grown at a 62.6% compound annual growth rate (CAGR), from -1.7% to -4.4%.
What does free cash flow yield mean?: Trailing-twelve-month free cash flow divided by market capitalization at the quarter end. The cash return the business generates relative to its market price.